Indications of radiotherapy;Indications actuelles de la radiotherapie exclusive

Revue des Maladies Respiratoires

Volumn 15, Issue 3 BIS, 1998, Pages 377-382

  Payne, D ^a   Van Houtte, P ^a  

^a NONE

Author keywords

Bronchial cancer; Radiotherapy

Indexed keywords

ARTICLE; BRONCHUS CANCER; CANCER RADIOTHERAPY; CANCER SIZE; HUMAN; RADIATION DOSE FRACTIONATION; TREATMENT INDICATION; CLASSIFICATION; COMPARATIVE STUDY; LUNG TUMOR; METASTASIS; PALLIATIVE THERAPY; PATIENT SELECTION; PROGNOSIS; RADIATION DOSE; REVIEW;

DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; RADIOTHERAPY DOSAGE;

EID: 0031838579     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. NON-SMALL CELL LUNG CANCER COLLABORATIVE GROUP : Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899-909.
2. DILLMAN RO, SEAGREN SL, PROPERT KJ et al. : A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 525:940-945.
3. HAZUKA MB, TURRISI AT, LUTz ST et al. : Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer : A retrospective multivariate analysis. Int J Radial Oncol Biol Phys 1993;27:273-284.
4. WÜRSCHMIDT D, BÜNEMANN H, BÜNEMANN C, BECK-BORN-HOLDT HP, HEILMANN HP : Inoperable non-small cell lung cancer : a retrospective analysis of 427 patients treated with high-dose radiotherapy. Int J Radiat Oncol Biol Phys 1994; 28:583-588.
5. Cox JD, PAJAK TF, ASBELL S et al. : Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung : Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 1993;27:493-498.
6. ARRIAGADA R, LE CHEVALIER T, QUOIX E et al. for the GETCB, the FNCLCC and the CEBI trialists. Effect of chemotherapy on locally advanced non-small lung carcinoma : a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
7. SCHAAKE-KONING C, VAN DEN BOGAERT W, DALESIO O et al. : Effects of concomitant cisplatin and radiotherapy on inoperablenon-small cell lung cancer. N Engl J Med 1992;326:524-530.
8. PEREZ CA, PAJAK TF, RUBIN P et al. : Long-term observations of the patterns of failure in patients with unresectable non oatcell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987;59:1874-1881.
9. DURCI ML, KOMAKI R, OSWALD MJ, MOUNTAIN CF : Comparison of surgery and radiation therapy for non-small cellcarcinoma of the lung with mediastinal metastasis. Int J Radiat Oncol Biol Phys 1991; 21:629-636.
10. DOSORETZ DE, KATIN MJ, BLITZER Ph et al. : Radiation therapy in the management of medically inoperable carcinoma of the lung : Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24:3-9.
11. VAN HOUTTE P, GREGOR A, PHLIPS P : International survey of radiotherapy practice for radical treatment of non-small cell lung cancer. Lung Cancer 1994;11 (suppl. 3):S129-138.
12. PEREZ CA, STANLEY K, GRUNDY G et al. : Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the Radiation Therapy Oncology Group. Cancer 1982;50:1091-1099.
13. SLOTMAN BJ, ANTONISSE IE, NJO KH : Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radioth Oncol 1996;41:41-44.
14. KOUKOURAKIS M, HLOUVERAKIS G, KOSMA L, SKARLATOS J, GIATROMANOLAKI A, YANNAKAKIS D : The impact of overall treatment time on the results of radiotherapy for Nonsmall cell lung carcinoma. Int J Radiat Oncol Biol Phys 1996;34:323-332.
15. PAESMANS M, SCULIER JP, LIBERT P et al. for the European Lung Cancer Working Party. Prognostic factors for survival in advanced non-small cell lung cancer : Univariate and multivariate analysis including recursive partitioning and amalgamation algorithms in 1502 patients. J. Clin. Oncol. 1995;13:1221-1230.
16. GRAHAM MV, PURDY JA, EMAMI B, MATTHEWS JW, HARMS WB : Preliminary results of a prospective trial using three-dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1995;33:993-1000.
17. SAUSE W, SCOTT C, TAYLOR S et al. : Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer. J Nat Cancer Inst 1994;87:198-205.
18. SALNDERS MI : Fractionation and dose in thoracic radiotherapy. Lung Cancer 1994;10 (suppl. 1):245-252.
19. SPEISER BL, SPRATLINO L : Remote afterloading brachytherapy for the local control of endobronchial carcinoma, Int J Radiat Oncol Biol Phys 1993;25.579-588.
20. Lo TCM, GIRSHOVICH L, HEALEY GH et al. : Low dose rate versus high dose rate intraluminal brachytherapy for malignant endobronchial tumors. Radiother Oncol 1995;35:193-197.
21. BLEEHEN N : Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991;63:265-270.
22. MACBETH FR, BOGLER JJ, HOPWOOD P et al. : Medical Research Council Lung Cancer Working Party. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clinal Oncology 1996;8:167-175.